SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006235
Filing Date
2020-05-11
Accepted
2020-05-11 16:03:49
Documents
81
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20200511x10q.htm   iXBRL 10-Q 1852112
2 EX-31.1 icpt-20200331xex31d1.htm EX-31.1 12870
3 EX-31.2 icpt-20200331xex31d2.htm EX-31.2 12578
4 EX-32.1 icpt-20200331xex32d1.htm EX-32.1 14578
  Complete submission text file 0001558370-20-006235.txt   7345618

Data Files

Seq Description Document Type Size
5 EX-101.SCH icpt-20200511.xsd EX-101.SCH 46650
6 EX-101.CAL icpt-20200511_cal.xml EX-101.CAL 65594
7 EX-101.DEF icpt-20200511_def.xml EX-101.DEF 135723
8 EX-101.LAB icpt-20200511_lab.xml EX-101.LAB 381571
9 EX-101.PRE icpt-20200511_pre.xml EX-101.PRE 330343
15 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20200511x10q_htm.xml XML 1423188
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 20864703
SIC: 2834 Pharmaceutical Preparations